Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer

✍ Scribed by Roca, José-María; Alonso, Vicente; Pericay, Carles; Escudero, Pilar; Salud, Antonieta; Losa, Ferrán; López, Luis-Jesús; Guasch, Imma; Méndez, Miguel; Quintero-Aldana, Guillermo; Grande, Carlos; Vicente, Pilar; Arrivi, Antonio; Martin, Cristina; Moreno, Isabel; García, Pilar; Antón, Isabel; Constenla, Manuel; Yubero, Alfonso; Cirera, Luis

• Book ID: 118047784
• Publisher: S. Karger AG
• Year: 2010
• Tongue: English
• Weight: 125 KB
• Volume: 56
• Category: Article
• ISSN: 0009-3157
• DOI: 10.1159/000313527